Hepatic antigen-presenting cells and regulation of liver transplant outcome

Immunol Res. 2011 Aug;50(2-3):221-7. doi: 10.1007/s12026-011-8223-0.

Abstract

In the steady state, hepatic antigen (Ag)-presenting cells (APC) generally dampen systemic inflammatory responses to gut-derived Ags. Our studies focus on the role of specific liver APC populations, both non-parenchymal cells (dendritic cells [DC], Kupffer cells, and hepatic stellate cells [HSC]) and parenchymal cells, in the molecular regulation of tissue damage (ischemia and reperfusion [I/R] injury) and immunity following liver transplantation. We focus on factors that either promote or overwhelm the natural tendency of the liver to suppress inflammatory/immune responses. We are also examining molecular mechanisms that regulate liver DC maturation and function and that determine their role in the control of allogeneic T-cell function and the fate of the transplanted liver. Our studies are also aimed at elucidating mechanisms by which HSC regulate DC and T-cell function. These investigations may provide new targets for therapeutic intervention in liver inflammation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antigen-Presenting Cells / immunology*
  • Antigen-Presenting Cells / metabolism*
  • Dendritic Cells / immunology
  • Dendritic Cells / metabolism
  • Dendritic Cells / ultrastructure
  • Hepatic Stellate Cells / immunology
  • Hepatic Stellate Cells / metabolism
  • Humans
  • Immune Tolerance / immunology
  • Immunity, Innate / immunology
  • Liver / immunology*
  • Liver / metabolism*
  • Liver Transplantation / immunology*
  • Mice
  • Reperfusion Injury / immunology
  • Reperfusion Injury / pathology